PCN114 IMPACT RCC REAL-WORLD STUDY: ECONOMIC IMPACT OF EARLY PROGRESSION AMONG PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS IN FIRST-LINE SETTING